Dulaglutide (Trulicity): The Third Once-Weekly GLP-1 Agonist

समान संसाधन

• Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes
  द्वारा: Fala, Loretta
  प्रकाशित: (2015)
• An overview of the once‐weekly GLP‐1 receptor agonists from the pharmacist’s perspective
  द्वारा: Patel, Dhiren
  प्रकाशित: (2020)
• Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices
  द्वारा: Zhou, Anna Y., और अन्य
  प्रकाशित: (2018)
• Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
  द्वारा: Mirabelli, Maria, और अन्य
  प्रकाशित: (2021)
• Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes
  द्वारा: Trujillo, Jennifer
  प्रकाशित: (2020)